Cian Healthcare Ltd. engages in the development and manufacture of pharmaceuticals, cosmeceuticals, and nutraceutical products. The company is headquartered in Pune, Maharashtra. The company went IPO on 2019-05-23. The firm is engaged in the manufacturing and marketing of pharmaceutical products. The company renders services for Third Party Pharmaceutical Manufacturing. The firm is engaged in manufacturing multiple lines- tablets, capsules, soft gels, liquid orals, ointments/ creams & sachets, and cosmetics. Its portfolio comprises of gynecology, haematinic, cardio-diabetic, orthopedic, pediatric, derma-cosmetic, antibiotic, CNS, and vitamins and nutrient products. The firm also exports its product to various countries, such as Afghanistan, Benin, Bhutan, Bolivia, Cambodia, and Sri Lanka. The company is also engaged in the business of manufacturing cosmetic products. The firm caters to approximately eight segments of the pharma industry (branches of medicines), including 500 brands across 11 product lines. The firm's subsidiary includes Dr. Smith Biotech Private Limited.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.
15 fields couldn't be derived. The company was scraped before the cash-flow and balance-sheet rows were captured. Re-running an analysis will refresh these.